Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levamlodipine Maleate (Xuanning) or Amlodipine Besylate (Norvasc) for Treatment of Hypertension: A Comparative Effectiveness Research

NCT01844570 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT01844570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01844570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levamlodipine Maleate (Xuanning) or Amlodipine Besylate (Norvasc) for Treatment of Hypertension: A Comparative Effectiveness Research
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2013
Completion date
December 31, 2015
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary hypertension